To describe the safety and tolerability of a single intravenous dose of MEDI-524 [clinicaltrials_resource:e78861db53da9ca1639170e938a42a97] - Clinical Trials - bio2rdf - TriplyDB

To describe the safety and tolerability of a single intravenous dose of MEDI-524 [clinicaltrials_resource:e78861db53da9ca1639170e938a42a97]

To describe the safety and tolerability of a single intravenous dose of MEDI-524 [clinicaltrials_resource:e78861db53da9ca1639170e938a42a97]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]

http://bio2rdf.org/clinicaltrials_resource:e78861db53da9ca1639170e938a42a97

To describe the safety and tolerability of a single intravenous dose of MEDI-524 [clinicaltrials_resource:e78861db53da9ca1639170e938a42a97]

Bio2RDF uri

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection [clinicaltrials:NCT00192504]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

To describe the safety and tolerability of a single intravenous dose of MEDI-524 [clinicaltrials_resource:e78861db53da9ca1639170e938a42a97]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]

http://bio2rdf.org/clinicaltrials_resource:e78861db53da9ca1639170e938a42a97

Bio2RDF identifier

e78861db53da9ca1639170e938a42a97

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials_resource

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials_resource:e78861db53da9ca1639170e938a42a97

http://www.w3.org/2001/XMLSchema#string

measure [clinicaltrials_vocabulary:measure]

To describe the safety and tolerability of a single intravenous dose of MEDI-524

http://www.w3.org/2001/XMLSchema#string

identifier

clinicaltrials_resource:e78861db53da9ca1639170e938a42a97

http://www.w3.org/2001/XMLSchema#string

title

To describe the safety and tolerability of a single intravenous dose of MEDI-524

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]

label

To describe the safety and tol ...... 861db53da9ca1639170e938a42a97]

@en